Urinary proteomic profiles distinguish between active and inactive lupus nephritis

被引:69
作者
Mosley, K. [1 ]
Tam, F. W. K. [1 ]
Edwards, R. J. [1 ]
Crozier, J. [1 ]
Pusey, C. D. [1 ]
Lightstone, L. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Div Med, Renal Sect, London W12 0NN, England
关键词
lupus nephritis; biomarkers; SELDI-TOF MS;
D O I
10.1093/rheumatology/kel351
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Key aims of the treatment of lupus nephritis (LN) are to induce and maintain remission with minimal side effects. However, assessing ongoing renal inflammatory activity is poorly served by current diagnostic tests apart from renal biopsy, but frequent biopsies cannot be justified. Our long-term aim is to identify novel biomarkers from urinary protein profiles to improve diagnosis and monitoring of activity and response to therapy in LN. Methods. We used surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) to identify biomarkers able to discriminate between urine samples from patients with inactive (n= 49) and active (n= 26) LN. Discriminant function analysis was used to define the minimum number of proteins whose levels best distinguished between the two patient groups. Serial urines of six biopsied patients were studied prospectively, and multiple regression (MR) scores calculated. Results. Proteins with masses of 3340 and 3980 distinguished active from inactive LN with 92% sensitivity and specificity of 92% each. The prospective study of the biopsied patients demonstrated that MR scores could predict both relapse and remission earlier than traditional clinical markers. Conclusions. SELDI-TOF MS identified potential biomarker profiles strongly associated with activity in LN. Identification of these proteins will allow us to devise specific assays to routinely monitor disease progression, and alter immunosuppressive drug regimens accordingly. These proteins may also play a critical role in the pathogenesis of glomerulonephritis, and could therefore provide targets for therapeutic intervention.
引用
收藏
页码:1497 / 1504
页数:8
相关论文
共 31 条
[1]   Measurement of urinary chemokine and growth factor messenger RNAs: A noninvasive monitoring in lupus nephritis [J].
Avihingsanon, Y ;
Phumesin, P ;
Benjachat, T ;
Akkasilpa, S ;
Kittikowit, V ;
Praditpornsilpa, K ;
Wongpiyabavorn, J ;
Eiam-Ong, S ;
Hemachudha, T ;
Tungsanga, K ;
Hirankarn, N .
KIDNEY INTERNATIONAL, 2006, 69 (04) :747-753
[2]   Alterations in renal degradation of albumin in early experimental diabetes in the rat: a new factor in the mechanism of albuminuria [J].
Burne, MJ ;
Panagiotopoulos, S ;
Jerums, G ;
Comper, WD .
CLINICAL SCIENCE, 1998, 95 (01) :67-72
[3]   Ace-enhanced laser desorption/lonization-time of flight-mass spectrometry (SELDI-TOF-MS): A new proteomic urinary test for patients with urolithiasis [J].
Cadieux, PA ;
Beiko, DT ;
Watterson, JD ;
Burton, JP ;
Howard, JC ;
Knudsen, BE ;
Gan, BS ;
McCormick, JK ;
Chambers, AF ;
Denstedt, JD ;
Reid, G .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2004, 18 (03) :170-175
[4]   The ProteinChip ® Biomarker System from Ciphergen Biosystems:: a novel proteomics platform for rapid biomarker discovery and validation [J].
Chapman, K .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 :82-87
[5]   Characterization of renal allograft rejection by urinary proteomic analysis [J].
Clarke, W ;
Silverman, BC ;
Zhang, Z ;
Chan, DW ;
Klein, AS ;
Molmenti, EP .
ANNALS OF SURGERY, 2003, 237 (05) :660-664
[6]   The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells [J].
Cutillas, PR ;
Chalkley, RJ ;
Hansen, KC ;
Cramer, R ;
Norden, AGW ;
Waterfield, MD ;
Burlingame, AL ;
Unwin, RJ .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 287 (03) :F353-F364
[7]   Degradation of albumin by the renal proximal tubule cells and the subsequent fate of its fragments [J].
Gudehithlu, KP ;
Pegoraro, AA ;
Dunea, G ;
Arruda, JAL ;
Singh, AK .
KIDNEY INTERNATIONAL, 2004, 65 (06) :2113-2122
[8]  
Hampel DJ, 2001, J AM SOC NEPHROL, V12, P1026, DOI 10.1681/ASN.V1251026
[9]   Outcome of relapse in lupus nephritis:: Roles of reversal of renal fibrosis and response of inflammation to therapy [J].
Hill, GS ;
Delahousse, M ;
Nochy, D ;
Thervet, É ;
Vrtovsnik, F ;
Rémy, P ;
Glotz, D ;
Bariéty, J .
KIDNEY INTERNATIONAL, 2002, 61 (06) :2176-2186
[10]   Characterization of the urinary albumin degradation pathway in the isolated perfused rat kidney [J].
Hilliard, LM ;
Osicka, TM ;
Clavant, SP ;
Robinson, PJ ;
Nikolic-Paterson, DJ ;
Comper, WD .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2006, 147 (01) :36-44